citalopram has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bordet, R; Derambure, P; Destée, A; Jacquesson, JM; Laloux, C; Monaca, C | 1 |
| Di Paolo, T; Morissette, M; Sánchez, MG | 1 |
2 other study(ies) available for citalopram and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
| Article | Year |
|---|---|
The effects of serotoninergic, noradrenergic, cholinergic and dopaminergic drugs on vigilance states in MPTP-treated mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Acyclovir; Adrenergic Uptake Inhibitors; Animals; Arecoline; Arousal; Behavior, Animal; Cholinergic Agonists; Citalopram; Desipramine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred C57BL; Neurotoxins; Neurotransmitter Uptake Inhibitors; Piperazines; Selective Serotonin Reuptake Inhibitors; Time Factors; Tyrosine 3-Monooxygenase | 2007 |
Estradiol and brain serotonin reuptake transporter in long-term ovariectomized parkinsonian monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Citalopram; Estradiol; Female; Macaca fascicularis; Microinjections; Ovariectomy; Parkinsonian Disorders; Postmenopause; Radionuclide Imaging; Serotonin Plasma Membrane Transport Proteins; Substantia Nigra; Tritium | 2013 |